2013
BM mesenchymal stromal cell–derived exosomes facilitate Multiple Myeloma progression
Journal of Clinical Investigation
BM mesenchymal stromal cell–derived exosomes facilitate Multiple Myeloma progression
Journal of Clinical Investigation
2011
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
Leukemia
Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to anti- tumor activity in Waldesntröm's Macroglobulinemia
Clinical Cancer Research
Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy
Journal of Biomedical Optics
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
Leukemia
Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to anti- tumor activity in Waldesntröm's Macroglobulinemia
Clinical Cancer Research
Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy
Journal of Biomedical Optics
HOME | OUR TEAM | PUBLICATIONS | CAREER OPPORTUNITIES | CONTACT US
© 2023 Ghobrial Lab at Dana-Farber Cancer Institute
© 2023 Ghobrial Lab at Dana-Farber Cancer Institute